Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Barbara Lavernos
Age : 54
Country of residence : Unknown
Linked companies : L'Oréal S.A. - Sanofi

Biography of Barbara Lavernos 
Ms. Barbara Lavernos is an Independent Director at Sanofi, a Deputy CEO-Research, Innovation & Technology at L'Oréal SA and a Chief Technology, Operations Officer & EVP at L'Oréal Canada, Inc. She is on the Board of Directors at Sanofi. She received her undergraduate degree from École des Hautes Études d’Ingénieur.


Current positions of Barbara Lavernos 
Barbara Lavernos : Personal Network 
Most Read News 
05/30Stellantis will need one or two additional U.S. battery plants - Tavares
RE
05/29Republicans speak out against US debt-ceiling deal, in sign of rocky road ahead
RE
06/05Exclusive-Crypto giant Binance controlled 'independent' US affiliate's bank accounts
RE
06/02JPMorgan's Dimon visits Taiwan to meet staff, clients -source
RE
06/06Microsoft's Smith meets UK finance minister after Activision block
RE
11:35aWEEKLY PREVIEW: Dates until June 20, 2023
DP
06/06Qantas CEO Alan Joyce sells $11 mln in shares ahead of retirement
RE
05/30Elon Musk kicks off China visit, Tesla expansion in focus
RE
06/05Exclusive-Musk's Neuralink valued at about $5 billion despite long road to market
RE
06/01Stellantis does not need Italy among its shareholders, Chairman Elkann says
RE
More news


© 2023 People and Ownership :   
Barbara Lavernos : Connections 


Latest news about Barbara Lavernos 
04/21Transcript : L'Oréal S.A. - Shareholder/Analyst Call
CI
2022Transcript : L'Oréal S.A. Presents at 19th annual dbAccess Global Consumer Conference 2022, Jun-14-2022
CI
2022Transcript : L'Oréal S.A. - Shareholder/Analyst Call
CI
2022L'Oréal S.A., 2021 Earnings Call, Feb 10, 2022
CI
2022Alphabet's unprofitable Verily unit in skin-care deal with L'Oreal
RE
2022Alphabet's unprofitable Verily unit in skin-care deal with L'Oreal
RE
More news

Secure and increase the performance of your investments with our team of experts at your side.
Securing my Investments
fermer